Brilivog M 500mg/0.3mg Tablet SR
Marketer
Osiante Biotech
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Brilivog M 500mg/0.3mg Tablet SR
Diabexe Duo 500mg/0.3mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication manages type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is vital, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are crucial for diabetes control. Possible side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions. These are typically transient and self-limiting. Persistent or concerning side effects warrant medical attention. Your doctor can offer strategies to manage or treat bothersome side effects. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Brilivog M 500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Brilivog M 500mg/0.3mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Brilivog M 500mg/0.3mg sustained-release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
Common Side effects of Brilivog M 500mg/0.3mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Brilivog M 500mg/0.3mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Brilivog M 500mg/0.3mg Extended-Release Tablet with food.
How Brilivog M 500mg/0.3mg Tablet SR works:
Brilivog M 500mg/0.3mg extended-release tablets contain a dual-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Brilivog M 500mg/0.3mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Brilivog M 500mg/0.3mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. Prescribing this medication will involve a careful assessment of benefits against potential hazards by your physician. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Brilivog M 500mg/0.3mg tablet is likely not safe for breastfeeding mothers. Available evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Extended-release Brilivog M 500mg/0.3mg tablets typically do not impair driving ability. Nevertheless, individuals using this medication concurrently with other diabetes treatments like sulfonylureas, insulin, or repaglinide should be aware of the potential for low blood sugar.
KidneyCAUTION
Exercise caution when administering Brilivog M 500mg/0.3mg Tablet SR to individuals with kidney impairment; dosage modification may be necessary. Physician consultation is recommended. Brilivog M 500mg/0.3mg Tablet SR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is advised during treatment.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Brilivog M 500mg/0.3mg sustained-release tablets in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Brilivog M 500mg/0.3mg Tablet SR :
Should you forget to take your Brilivog M 500mg/0.3mg Tablet SR, administer the dose at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Brilivog M 500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently